
EIT Health
Description
EIT Health is a leading European network focused on promoting entrepreneurship and innovation in healthy living and active aging. As one of the largest healthcare initiatives funded by the European Institute of Innovation and Technology (EIT), an EU body, it operates not as a traditional venture capital fund but as a comprehensive ecosystem builder. Its primary goal is to accelerate the development and market adoption of innovative health solutions, fostering collaboration between businesses, research institutions, and universities across Europe. EIT Health's extensive network and strategic programs aim to improve the quality of life for European citizens and strengthen the continent's healthcare industry.
The organization provides substantial support to startups and SMEs through various programs, which include non-dilutive funding, mentorship, education, and access to a vast network of experts and potential investors. For instance, its 'Headstart' program typically offers up to €50,000 (approximately $54,000 USD) in non-dilutive grants to early-stage companies for product validation and market entry. More mature ventures can access the 'Catapult' program, which provides up to €250,000 (approximately $270,000 USD) in convertible loans or equity-free funding, alongside intensive business development support and investor pitching opportunities.
EIT Health's impact is significant, having supported over 700 startups by 2022, contributing to the launch of numerous health innovations. Beyond direct funding, it plays a crucial role in talent development through educational programs and in facilitating cross-border collaboration within the European health sector. Its funding model emphasizes de-risking early-stage ventures and preparing them for subsequent private investment, thereby bridging the gap between research and market-ready solutions in the health domain.
Investor Profile
EIT Health has backed more than 93 startups, with 0 new investments in the last 12 months alone. The firm has led 54 rounds, about 58% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Pre Seed, Seed rounds (top funding stages).
- Majority of deals are located in Spain, United Kingdom, Switzerland.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $54K – $270K.
Stage Focus
- Grant (69%)
- Pre Seed (20%)
- Seed (4%)
- Series A (2%)
- Non Equity Assistance (2%)
- Series Unknown (1%)
- Convertible Note (1%)
Country Focus
- Spain (20%)
- United Kingdom (18%)
- Switzerland (12%)
- Ireland (11%)
- Germany (8%)
- Italy (4%)
- The Netherlands (4%)
- Portugal (3%)
- Romania (3%)
- France (2%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Artificial Intelligence (Ai)
- Software
- Machine Learning
- Health Diagnostics
- Life Science
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.